Nathaniel MacApagal

Director, Downstream and Drug Conjugation Process Development @Arrivent Biopharma

Germantown, MD, US
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

Mar 2025 — Present

Director, Downstream and Drug Conjugation Process Development @Arrivent Biopharma

View department →

Gaithersburg, MD, US

Leads the development of purification and drug conjugation processes for manufacturing next-generation antibody-drug conjugates (ADCs) designed for advanced cancer therapy.

EDUCATION

N/A

The Johns Hopkins University

Master of Business Administration - MBA, Entrepreneurship, Innovation, and Technology

2002 — 2006

University of Delaware

Master of Science - MS, Chemical Engineering

N/A

Rutgers University

Bachelor of Science - BS, Chemical Engineering

SKILLS

Recombinant Dna TechnologyGmpV&VMolecular BiologyProcess SimulationWestern BlottingSds-PageVaccinesProtein ChemistryChromatographyCell CulturePurificationMonoclonal AntibodiesUv/VisGlpAntibodiesBiopharmaceuticalsElisaFiltrationQuality by DesignSopHplcBiotechnologyProtein PurificationDesign of ExperimentsMolecular CloningValidationAnalytical BiochemistryTechnology Transfer

ABOUT NATHANIEL MACAPAGAL

Nathaniel Macapagal, M.S.Ch.E is a biopharmaceutical industry expert with two decades of experience in process and drug product development who has helped bring several medicines to market.

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.